nodes	percent_of_prediction	percent_of_DWPC	metapath
Olanzapine—ALB—Captopril—systemic scleroderma	0.0923	0.118	CbGbCtD
Olanzapine—CYP1A2—Pentoxifylline—systemic scleroderma	0.0738	0.0945	CbGbCtD
Olanzapine—ALB—Mycophenolate mofetil—systemic scleroderma	0.0727	0.0931	CbGbCtD
Olanzapine—CYP1A2—Leflunomide—systemic scleroderma	0.0704	0.0902	CbGbCtD
Olanzapine—ABCB1—Lisinopril—systemic scleroderma	0.0645	0.0827	CbGbCtD
Olanzapine—CYP2C9—Leflunomide—systemic scleroderma	0.0634	0.0813	CbGbCtD
Olanzapine—ALB—Prednisone—systemic scleroderma	0.0581	0.0745	CbGbCtD
Olanzapine—ABCB1—Captopril—systemic scleroderma	0.0483	0.0619	CbGbCtD
Olanzapine—CYP2D6—Captopril—systemic scleroderma	0.0455	0.0583	CbGbCtD
Olanzapine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.038	0.0487	CbGbCtD
Olanzapine—CYP2C19—Prednisone—systemic scleroderma	0.0377	0.0483	CbGbCtD
Olanzapine—ABCB1—Prednisone—systemic scleroderma	0.0304	0.0389	CbGbCtD
Olanzapine—HTR2B—cardial valve—systemic scleroderma	0.0301	0.14	CbGeAlD
Olanzapine—ALB—Methotrexate—systemic scleroderma	0.0292	0.0374	CbGbCtD
Olanzapine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0228	0.0292	CbGbCtD
Olanzapine—HTR3A—myenteric nerve plexus—systemic scleroderma	0.0227	0.106	CbGeAlD
Olanzapine—CYP2C9—cardial valve—systemic scleroderma	0.0195	0.091	CbGeAlD
Olanzapine—CYP3A4—Prednisone—systemic scleroderma	0.0182	0.0233	CbGbCtD
Olanzapine—ABCB1—Methotrexate—systemic scleroderma	0.0152	0.0195	CbGbCtD
Olanzapine—HTR7—myenteric nerve plexus—systemic scleroderma	0.0147	0.0687	CbGeAlD
Olanzapine—HTR7—pulmonary artery—systemic scleroderma	0.0104	0.0486	CbGeAlD
Olanzapine—HTR2A—myenteric nerve plexus—systemic scleroderma	0.00918	0.0428	CbGeAlD
Olanzapine—HTR2A—pulmonary artery—systemic scleroderma	0.0065	0.0303	CbGeAlD
Olanzapine—HTR1B—artery—systemic scleroderma	0.00501	0.0234	CbGeAlD
Olanzapine—HTR1D—artery—systemic scleroderma	0.00485	0.0226	CbGeAlD
Olanzapine—HTR1B—blood vessel—systemic scleroderma	0.0039	0.0182	CbGeAlD
Olanzapine—HTR7—artery—systemic scleroderma	0.00386	0.018	CbGeAlD
Olanzapine—HTR1D—blood vessel—systemic scleroderma	0.00378	0.0176	CbGeAlD
Olanzapine—HTR7—endothelium—systemic scleroderma	0.00326	0.0152	CbGeAlD
Olanzapine—HTR7—blood vessel—systemic scleroderma	0.00301	0.014	CbGeAlD
Olanzapine—HRH2—skin of body—systemic scleroderma	0.00274	0.0128	CbGeAlD
Olanzapine—CHRM5—skin of body—systemic scleroderma	0.00262	0.0122	CbGeAlD
Olanzapine—H1F0—connective tissue—systemic scleroderma	0.0025	0.0117	CbGeAlD
Olanzapine—HTR2A—artery—systemic scleroderma	0.00241	0.0112	CbGeAlD
Olanzapine—H1F0—smooth muscle tissue—systemic scleroderma	0.00229	0.0107	CbGeAlD
Olanzapine—H1F0—skin of body—systemic scleroderma	0.00226	0.0105	CbGeAlD
Olanzapine—HRH2—digestive system—systemic scleroderma	0.00219	0.0102	CbGeAlD
Olanzapine—FMO3—lung—systemic scleroderma	0.00206	0.0096	CbGeAlD
Olanzapine—HTR2A—endothelium—systemic scleroderma	0.00203	0.0095	CbGeAlD
Olanzapine—HTR1D—connective tissue—systemic scleroderma	0.00194	0.00904	CbGeAlD
Olanzapine—HTR2A—blood vessel—systemic scleroderma	0.00188	0.00876	CbGeAlD
Olanzapine—HRH2—lung—systemic scleroderma	0.00183	0.00854	CbGeAlD
Olanzapine—H1F0—digestive system—systemic scleroderma	0.00181	0.00843	CbGeAlD
Olanzapine—HTR3A—digestive system—systemic scleroderma	0.00172	0.00804	CbGeAlD
Olanzapine—H1F0—tendon—systemic scleroderma	0.00172	0.00802	CbGeAlD
Olanzapine—HTR2B—smooth muscle tissue—systemic scleroderma	0.00165	0.00769	CbGeAlD
Olanzapine—HTR2B—skin of body—systemic scleroderma	0.00163	0.00759	CbGeAlD
Olanzapine—HTR7—connective tissue—systemic scleroderma	0.00154	0.0072	CbGeAlD
Olanzapine—H1F0—lung—systemic scleroderma	0.00151	0.00704	CbGeAlD
Olanzapine—CHRM3—smooth muscle tissue—systemic scleroderma	0.00148	0.00692	CbGeAlD
Olanzapine—HTR3A—lung—systemic scleroderma	0.00144	0.00671	CbGeAlD
Olanzapine—HTR7—smooth muscle tissue—systemic scleroderma	0.00141	0.00659	CbGeAlD
Olanzapine—HTR2B—digestive system—systemic scleroderma	0.0013	0.00607	CbGeAlD
Olanzapine—ORM1—lung—systemic scleroderma	0.00129	0.00601	CbGeAlD
Olanzapine—HTR2B—tendon—systemic scleroderma	0.00124	0.00578	CbGeAlD
Olanzapine—ABCB1—blood vessel—systemic scleroderma	0.00123	0.00574	CbGeAlD
Olanzapine—CHRM3—digestive system—systemic scleroderma	0.00117	0.00546	CbGeAlD
Olanzapine—HRH1—connective tissue—systemic scleroderma	0.00115	0.00538	CbGeAlD
Olanzapine—ADRA2A—connective tissue—systemic scleroderma	0.00113	0.00528	CbGeAlD
Olanzapine—HTR7—digestive system—systemic scleroderma	0.00111	0.0052	CbGeAlD
Olanzapine—CHRM1—lung—systemic scleroderma	0.00109	0.0051	CbGeAlD
Olanzapine—CYP2C19—digestive system—systemic scleroderma	0.00109	0.00508	CbGeAlD
Olanzapine—HTR2B—lung—systemic scleroderma	0.00109	0.00507	CbGeAlD
Olanzapine—HTR7—tendon—systemic scleroderma	0.00106	0.00495	CbGeAlD
Olanzapine—HRH1—smooth muscle tissue—systemic scleroderma	0.00105	0.00492	CbGeAlD
Olanzapine—ADRA2C—tendon—systemic scleroderma	0.000975	0.00455	CbGeAlD
Olanzapine—HTR2A—connective tissue—systemic scleroderma	0.000962	0.00449	CbGeAlD
Olanzapine—HTR7—lung—systemic scleroderma	0.000931	0.00434	CbGeAlD
Olanzapine—CYP1A2—digestive system—systemic scleroderma	0.000889	0.00415	CbGeAlD
Olanzapine—HTR2A—smooth muscle tissue—systemic scleroderma	0.00088	0.00411	CbGeAlD
Olanzapine—DRD2—lung—systemic scleroderma	0.00088	0.00411	CbGeAlD
Olanzapine—ADRA2C—lung—systemic scleroderma	0.000855	0.00399	CbGeAlD
Olanzapine—CYP2C9—digestive system—systemic scleroderma	0.000844	0.00394	CbGeAlD
Olanzapine—HRH1—digestive system—systemic scleroderma	0.000832	0.00388	CbGeAlD
Olanzapine—HRH1—tendon—systemic scleroderma	0.000792	0.0037	CbGeAlD
Olanzapine—ADRA2A—tendon—systemic scleroderma	0.000778	0.00363	CbGeAlD
Olanzapine—CYP1A2—lung—systemic scleroderma	0.000742	0.00346	CbGeAlD
Olanzapine—HTR2A—digestive system—systemic scleroderma	0.000695	0.00324	CbGeAlD
Olanzapine—HRH1—lung—systemic scleroderma	0.000695	0.00324	CbGeAlD
Olanzapine—ADRA2A—lung—systemic scleroderma	0.000683	0.00319	CbGeAlD
Olanzapine—HTR2A—tendon—systemic scleroderma	0.000661	0.00309	CbGeAlD
Olanzapine—CYP3A4—digestive system—systemic scleroderma	0.000643	0.003	CbGeAlD
Olanzapine—CYP2D6—digestive system—systemic scleroderma	0.000633	0.00296	CbGeAlD
Olanzapine—HTR2A—lung—systemic scleroderma	0.00058	0.00271	CbGeAlD
Olanzapine—ABCB1—digestive system—systemic scleroderma	0.000455	0.00213	CbGeAlD
Olanzapine—ABCB1—lung—systemic scleroderma	0.00038	0.00178	CbGeAlD
Olanzapine—HTR5A—Signaling Pathways—MMP9—systemic scleroderma	3.66e-06	0.000696	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—HSPG2—systemic scleroderma	3.65e-06	0.000694	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—CSK—systemic scleroderma	3.65e-06	0.000693	CbGpPWpGaD
Olanzapine—ADRA1B—GPCR downstream signaling—EDN1—systemic scleroderma	3.63e-06	0.00069	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—CSK—systemic scleroderma	3.63e-06	0.000689	CbGpPWpGaD
Olanzapine—ADRA2A—GPCR ligand binding—CCL2—systemic scleroderma	3.62e-06	0.000689	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—EDN1—systemic scleroderma	3.6e-06	0.000684	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—HSPG2—systemic scleroderma	3.6e-06	0.000683	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling by GPCR—EDN1—systemic scleroderma	3.59e-06	0.000681	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—EDN1—systemic scleroderma	3.58e-06	0.00068	CbGpPWpGaD
Olanzapine—ADRA2C—Hemostasis—NOS3—systemic scleroderma	3.56e-06	0.000676	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—HSPG2—systemic scleroderma	3.55e-06	0.000675	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—CSK—systemic scleroderma	3.53e-06	0.000671	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—RHOB—systemic scleroderma	3.52e-06	0.000668	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—CSK—systemic scleroderma	3.47e-06	0.00066	CbGpPWpGaD
Olanzapine—HTR1A—Signaling by GPCR—EDN1—systemic scleroderma	3.46e-06	0.000658	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—RHOB—systemic scleroderma	3.46e-06	0.000657	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—RHOB—systemic scleroderma	3.45e-06	0.000656	CbGpPWpGaD
Olanzapine—HTR2C—Signaling by GPCR—EDN1—systemic scleroderma	3.44e-06	0.000654	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—RHOB—systemic scleroderma	3.44e-06	0.000654	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—RHOB—systemic scleroderma	3.43e-06	0.000652	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—RHOB—systemic scleroderma	3.4e-06	0.000645	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—RHOB—systemic scleroderma	3.39e-06	0.000644	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—EDN1—systemic scleroderma	3.35e-06	0.000636	CbGpPWpGaD
Olanzapine—DRD2—GPCR downstream signaling—EDN1—systemic scleroderma	3.35e-06	0.000636	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	3.33e-06	0.000634	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—HSPG2—systemic scleroderma	3.32e-06	0.00063	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—CTGF—systemic scleroderma	3.31e-06	0.000629	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—EDN1—systemic scleroderma	3.3e-06	0.000626	CbGpPWpGaD
Olanzapine—HTR2A—GPCR downstream signaling—EDN1—systemic scleroderma	3.29e-06	0.000626	CbGpPWpGaD
Olanzapine—HRH1—GPCR downstream signaling—EDN1—systemic scleroderma	3.29e-06	0.000624	CbGpPWpGaD
Olanzapine—CHRM1—GPCR downstream signaling—EDN1—systemic scleroderma	3.27e-06	0.000622	CbGpPWpGaD
Olanzapine—CHRM3—GPCR downstream signaling—EDN1—systemic scleroderma	3.26e-06	0.00062	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—HSPG2—systemic scleroderma	3.26e-06	0.00062	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—HSPG2—systemic scleroderma	3.26e-06	0.000619	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—HSPG2—systemic scleroderma	3.24e-06	0.000617	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—HSPG2—systemic scleroderma	3.23e-06	0.000615	CbGpPWpGaD
Olanzapine—CHRM2—GPCR downstream signaling—EDN1—systemic scleroderma	3.23e-06	0.000614	CbGpPWpGaD
Olanzapine—ADRA1A—GPCR downstream signaling—EDN1—systemic scleroderma	3.22e-06	0.000613	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—HSPG2—systemic scleroderma	3.2e-06	0.000609	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—CSK—systemic scleroderma	3.2e-06	0.000609	CbGpPWpGaD
Olanzapine—HTR6—Signaling by GPCR—CCL2—systemic scleroderma	3.2e-06	0.000607	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—HSPG2—systemic scleroderma	3.19e-06	0.000607	CbGpPWpGaD
Olanzapine—HTR7—Signaling by GPCR—CCL2—systemic scleroderma	3.19e-06	0.000607	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—CCL2—systemic scleroderma	3.17e-06	0.000603	CbGpPWpGaD
Olanzapine—HTR1D—Signaling by GPCR—CCL2—systemic scleroderma	3.17e-06	0.000603	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—CSK—systemic scleroderma	3.15e-06	0.000599	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—RHOB—systemic scleroderma	3.15e-06	0.000598	CbGpPWpGaD
Olanzapine—ALB—Hemostasis—MMP1—systemic scleroderma	3.14e-06	0.000597	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—CSK—systemic scleroderma	3.14e-06	0.000597	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—CSK—systemic scleroderma	3.13e-06	0.000596	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—CSK—systemic scleroderma	3.12e-06	0.000594	CbGpPWpGaD
Olanzapine—HTR1B—Signaling by GPCR—CCL2—systemic scleroderma	3.11e-06	0.00059	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—CSK—systemic scleroderma	3.09e-06	0.000588	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—CSK—systemic scleroderma	3.09e-06	0.000586	CbGpPWpGaD
Olanzapine—DRD4—Signaling by GPCR—CCL2—systemic scleroderma	3.06e-06	0.000581	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—EDN1—systemic scleroderma	3.04e-06	0.000577	CbGpPWpGaD
Olanzapine—HTR5A—Signaling Pathways—TGFB1—systemic scleroderma	3.02e-06	0.000573	CbGpPWpGaD
Olanzapine—CHRM4—Signaling by GPCR—CCL2—systemic scleroderma	3.01e-06	0.000573	CbGpPWpGaD
Olanzapine—ADRA2A—GPCR downstream signaling—EDN1—systemic scleroderma	3e-06	0.000569	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—EDN1—systemic scleroderma	2.99e-06	0.000568	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—EDN1—systemic scleroderma	2.98e-06	0.000567	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—EDN1—systemic scleroderma	2.97e-06	0.000565	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—HSPG2—systemic scleroderma	2.97e-06	0.000564	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—EDN1—systemic scleroderma	2.96e-06	0.000563	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—EDN1—systemic scleroderma	2.94e-06	0.000558	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—CTGF—systemic scleroderma	2.93e-06	0.000557	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—EDN1—systemic scleroderma	2.93e-06	0.000556	CbGpPWpGaD
Olanzapine—ALB—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	2.92e-06	0.000556	CbGpPWpGaD
Olanzapine—HTR2B—Signaling by GPCR—CCL2—systemic scleroderma	2.92e-06	0.000554	CbGpPWpGaD
Olanzapine—ADRA2A—Hemostasis—NOS3—systemic scleroderma	2.89e-06	0.000549	CbGpPWpGaD
Olanzapine—CHRM5—Signaling by GPCR—CCL2—systemic scleroderma	2.89e-06	0.000549	CbGpPWpGaD
Olanzapine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	2.88e-06	0.000547	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CSK—systemic scleroderma	2.87e-06	0.000545	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—NOS3—systemic scleroderma	2.83e-06	0.000538	CbGpPWpGaD
Olanzapine—ALB—Metabolism—HSPG2—systemic scleroderma	2.8e-06	0.000532	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—CCL2—systemic scleroderma	2.76e-06	0.000525	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—EDN1—systemic scleroderma	2.76e-06	0.000525	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—EDN1—systemic scleroderma	2.76e-06	0.000524	CbGpPWpGaD
Olanzapine—DRD1—Signaling by GPCR—CCL2—systemic scleroderma	2.75e-06	0.000523	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—EDN1—systemic scleroderma	2.74e-06	0.000521	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—EDN1—systemic scleroderma	2.72e-06	0.000517	CbGpPWpGaD
Olanzapine—DRD3—Signaling by GPCR—CCL2—systemic scleroderma	2.71e-06	0.000516	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—CTGF—systemic scleroderma	2.69e-06	0.000511	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—EDN1—systemic scleroderma	2.68e-06	0.00051	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—EDN1—systemic scleroderma	2.64e-06	0.000502	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—EDN1—systemic scleroderma	2.61e-06	0.000495	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—EDN1—systemic scleroderma	2.52e-06	0.000479	CbGpPWpGaD
Olanzapine—ADRA2B—Hemostasis—TGFB1—systemic scleroderma	2.52e-06	0.000478	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—HSPG2—systemic scleroderma	2.51e-06	0.000478	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—EDN1—systemic scleroderma	2.5e-06	0.000474	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—NOS3—systemic scleroderma	2.46e-06	0.000468	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—CCL2—systemic scleroderma	2.46e-06	0.000468	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—HSPG2—systemic scleroderma	2.45e-06	0.000466	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling by GPCR—CCL2—systemic scleroderma	2.45e-06	0.000466	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—CCL2—systemic scleroderma	2.45e-06	0.000465	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—EDN1—systemic scleroderma	2.38e-06	0.000452	CbGpPWpGaD
Olanzapine—HTR1A—Signaling by GPCR—CCL2—systemic scleroderma	2.37e-06	0.00045	CbGpPWpGaD
Olanzapine—HTR2C—Signaling by GPCR—CCL2—systemic scleroderma	2.35e-06	0.000447	CbGpPWpGaD
Olanzapine—ADRA2C—Hemostasis—TGFB1—systemic scleroderma	2.35e-06	0.000447	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—EDN1—systemic scleroderma	2.35e-06	0.000446	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—HSPG2—systemic scleroderma	2.31e-06	0.00044	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—HSPG2—systemic scleroderma	2.29e-06	0.000436	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—CCL2—systemic scleroderma	2.29e-06	0.000435	CbGpPWpGaD
Olanzapine—ALB—Hemostasis—NOS3—systemic scleroderma	2.28e-06	0.000433	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—MMP9—systemic scleroderma	2.27e-06	0.000431	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—CCL2—systemic scleroderma	2.25e-06	0.000428	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—NOS3—systemic scleroderma	2.19e-06	0.000417	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—NOS3—systemic scleroderma	2.18e-06	0.000414	CbGpPWpGaD
Olanzapine—ALB—Metabolism—CTGF—systemic scleroderma	2.12e-06	0.000403	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—EDN1—systemic scleroderma	2.12e-06	0.000402	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—CCL2—systemic scleroderma	2.08e-06	0.000395	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—EDN1—systemic scleroderma	2.04e-06	0.000389	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—CCL2—systemic scleroderma	2.04e-06	0.000388	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—CCL2—systemic scleroderma	2.04e-06	0.000388	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—EDN1—systemic scleroderma	2.03e-06	0.000387	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—CCL2—systemic scleroderma	2.03e-06	0.000386	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—CCL2—systemic scleroderma	2.03e-06	0.000385	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—CCL2—systemic scleroderma	2.01e-06	0.000381	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—CCL2—systemic scleroderma	2e-06	0.00038	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—EDN1—systemic scleroderma	1.98e-06	0.000376	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—MMP9—systemic scleroderma	1.98e-06	0.000376	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—HSPG2—systemic scleroderma	1.96e-06	0.000372	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—EDN1—systemic scleroderma	1.95e-06	0.00037	CbGpPWpGaD
Olanzapine—ADRA2A—Hemostasis—TGFB1—systemic scleroderma	1.91e-06	0.000363	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—CTGF—systemic scleroderma	1.91e-06	0.000362	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—CCL2—systemic scleroderma	1.89e-06	0.000359	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—CCL2—systemic scleroderma	1.89e-06	0.000358	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—CCL2—systemic scleroderma	1.87e-06	0.000356	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—TGFB1—systemic scleroderma	1.87e-06	0.000356	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—CTGF—systemic scleroderma	1.86e-06	0.000353	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—CCL2—systemic scleroderma	1.86e-06	0.000353	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—CCL2—systemic scleroderma	1.83e-06	0.000349	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—CCL2—systemic scleroderma	1.81e-06	0.000343	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—EDN1—systemic scleroderma	1.8e-06	0.000341	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—CCL2—systemic scleroderma	1.78e-06	0.000338	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—EDN1—systemic scleroderma	1.77e-06	0.000336	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—EDN1—systemic scleroderma	1.76e-06	0.000335	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—MMP9—systemic scleroderma	1.76e-06	0.000335	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—EDN1—systemic scleroderma	1.76e-06	0.000334	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—CTGF—systemic scleroderma	1.75e-06	0.000333	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—EDN1—systemic scleroderma	1.75e-06	0.000333	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—MMP9—systemic scleroderma	1.75e-06	0.000332	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—CTGF—systemic scleroderma	1.74e-06	0.00033	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—EDN1—systemic scleroderma	1.73e-06	0.00033	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—EDN1—systemic scleroderma	1.73e-06	0.000329	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—CCL2—systemic scleroderma	1.72e-06	0.000328	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—CCL2—systemic scleroderma	1.71e-06	0.000324	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—NOS3—systemic scleroderma	1.68e-06	0.00032	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—NOS3—systemic scleroderma	1.68e-06	0.000319	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—NOS3—systemic scleroderma	1.67e-06	0.000317	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—NOS3—systemic scleroderma	1.64e-06	0.000311	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—TGFB1—systemic scleroderma	1.63e-06	0.00031	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—CCL2—systemic scleroderma	1.63e-06	0.000309	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—NOS3—systemic scleroderma	1.61e-06	0.000306	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—EDN1—systemic scleroderma	1.61e-06	0.000305	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—CCL2—systemic scleroderma	1.6e-06	0.000305	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—NOS3—systemic scleroderma	1.59e-06	0.000302	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—NOS3—systemic scleroderma	1.54e-06	0.000292	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—NOS3—systemic scleroderma	1.52e-06	0.000289	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—HSPG2—systemic scleroderma	1.51e-06	0.000287	CbGpPWpGaD
Olanzapine—ALB—Hemostasis—TGFB1—systemic scleroderma	1.51e-06	0.000286	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—CTGF—systemic scleroderma	1.48e-06	0.000282	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—TGFB1—systemic scleroderma	1.45e-06	0.000276	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—NOS3—systemic scleroderma	1.45e-06	0.000275	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—CCL2—systemic scleroderma	1.45e-06	0.000275	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—TGFB1—systemic scleroderma	1.44e-06	0.000274	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—NOS3—systemic scleroderma	1.44e-06	0.000274	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—NOS3—systemic scleroderma	1.43e-06	0.000272	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—CCL2—systemic scleroderma	1.4e-06	0.000266	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—CCL2—systemic scleroderma	1.39e-06	0.000264	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—CCL2—systemic scleroderma	1.35e-06	0.000257	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—MMP9—systemic scleroderma	1.35e-06	0.000257	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—MMP9—systemic scleroderma	1.35e-06	0.000256	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—MMP9—systemic scleroderma	1.34e-06	0.000255	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—CCL2—systemic scleroderma	1.33e-06	0.000253	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—MMP9—systemic scleroderma	1.31e-06	0.000249	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—MMP9—systemic scleroderma	1.29e-06	0.000245	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—NOS3—systemic scleroderma	1.29e-06	0.000245	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—NOS3—systemic scleroderma	1.28e-06	0.000242	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—MMP9—systemic scleroderma	1.27e-06	0.000242	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—NOS3—systemic scleroderma	1.25e-06	0.000237	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—NOS3—systemic scleroderma	1.24e-06	0.000236	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—MMP9—systemic scleroderma	1.23e-06	0.000234	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—CCL2—systemic scleroderma	1.23e-06	0.000233	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—MMP9—systemic scleroderma	1.22e-06	0.000232	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—CCL2—systemic scleroderma	1.21e-06	0.000229	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—NOS3—systemic scleroderma	1.21e-06	0.000229	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—CCL2—systemic scleroderma	1.2e-06	0.000229	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—CCL2—systemic scleroderma	1.2e-06	0.000228	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—CCL2—systemic scleroderma	1.2e-06	0.000227	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—NOS3—systemic scleroderma	1.19e-06	0.000225	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—CCL2—systemic scleroderma	1.19e-06	0.000225	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—CCL2—systemic scleroderma	1.18e-06	0.000225	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—NOS3—systemic scleroderma	1.17e-06	0.000223	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—MMP9—systemic scleroderma	1.16e-06	0.000221	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—MMP9—systemic scleroderma	1.15e-06	0.000218	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—CTGF—systemic scleroderma	1.15e-06	0.000218	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—TGFB1—systemic scleroderma	1.11e-06	0.000211	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—TGFB1—systemic scleroderma	1.11e-06	0.000211	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—TGFB1—systemic scleroderma	1.1e-06	0.00021	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CCL2—systemic scleroderma	1.1e-06	0.000209	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—NOS3—systemic scleroderma	1.09e-06	0.000208	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—TGFB1—systemic scleroderma	1.08e-06	0.000205	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—NOS3—systemic scleroderma	1.08e-06	0.000205	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—NOS3—systemic scleroderma	1.07e-06	0.000204	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—NOS3—systemic scleroderma	1.07e-06	0.000203	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—NOS3—systemic scleroderma	1.07e-06	0.000203	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—TGFB1—systemic scleroderma	1.06e-06	0.000202	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—NOS3—systemic scleroderma	1.06e-06	0.000201	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—NOS3—systemic scleroderma	1.05e-06	0.0002	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—TGFB1—systemic scleroderma	1.05e-06	0.000199	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—MMP9—systemic scleroderma	1.04e-06	0.000197	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—TGFB1—systemic scleroderma	1.02e-06	0.000193	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—TGFB1—systemic scleroderma	1.01e-06	0.000191	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—MMP9—systemic scleroderma	9.99e-07	0.00019	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—MMP9—systemic scleroderma	9.94e-07	0.000189	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—NOS3—systemic scleroderma	9.79e-07	0.000186	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MMP9—systemic scleroderma	9.67e-07	0.000184	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—TGFB1—systemic scleroderma	9.58e-07	0.000182	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MMP9—systemic scleroderma	9.52e-07	0.000181	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—TGFB1—systemic scleroderma	9.45e-07	0.00018	CbGpPWpGaD
Olanzapine—ALB—Metabolism—NOS3—systemic scleroderma	9.24e-07	0.000176	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MMP9—systemic scleroderma	8.77e-07	0.000167	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MMP9—systemic scleroderma	8.63e-07	0.000164	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MMP9—systemic scleroderma	8.62e-07	0.000164	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MMP9—systemic scleroderma	8.59e-07	0.000163	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MMP9—systemic scleroderma	8.56e-07	0.000163	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—TGFB1—systemic scleroderma	8.53e-07	0.000162	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MMP9—systemic scleroderma	8.48e-07	0.000161	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MMP9—systemic scleroderma	8.45e-07	0.000161	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—NOS3—systemic scleroderma	8.3e-07	0.000158	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—TGFB1—systemic scleroderma	8.24e-07	0.000157	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—TGFB1—systemic scleroderma	8.19e-07	0.000156	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—NOS3—systemic scleroderma	8.1e-07	0.000154	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—TGFB1—systemic scleroderma	7.97e-07	0.000151	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MMP9—systemic scleroderma	7.86e-07	0.000149	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—TGFB1—systemic scleroderma	7.84e-07	0.000149	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—NOS3—systemic scleroderma	7.63e-07	0.000145	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—NOS3—systemic scleroderma	7.56e-07	0.000144	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—TGFB1—systemic scleroderma	7.23e-07	0.000137	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—TGFB1—systemic scleroderma	7.12e-07	0.000135	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—TGFB1—systemic scleroderma	7.1e-07	0.000135	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—TGFB1—systemic scleroderma	7.08e-07	0.000135	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—TGFB1—systemic scleroderma	7.06e-07	0.000134	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—TGFB1—systemic scleroderma	6.99e-07	0.000133	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—TGFB1—systemic scleroderma	6.97e-07	0.000132	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TGFB1—systemic scleroderma	6.47e-07	0.000123	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—NOS3—systemic scleroderma	6.46e-07	0.000123	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—NOS3—systemic scleroderma	4.99e-07	9.48e-05	CbGpPWpGaD
